NCT01774032View on ClinicalTrials.gov

H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older

PHASE3CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

October 31, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

H5N1 Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated), non-adjuvanted formulation

Trial Locations (2)

812-0025

PS Clinic, Fukuoka

532-0003

Osaka Pharmacology Clinical Research Hospital (OPHAC Hospital), Osaka

All Listed Sponsors
lead

Alachua Government Services, Inc.

INDUSTRY

NCT01774032 - H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older | Biotech Hunter | Biotech Hunter